Cannabis Law Report

DECEMBER 20, 2021

(“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., Virpax is initially seeking FDA approval of its three patented drug delivery platforms.

Clinical Trials 40

Clinical Trials Chronic Pain Pharmaceutical Data 40

Cannabis Law Report

JULY 8, 2021

Following the execution of this work, cbdMD Therapeutics will perform the requisite toxicological studies with Ion Tox, a leading in vitro toxicology and ADME-PK testing company, to support the safety of the cannabinoids of interest.

Research and Development 85

Research and Development Pets Cannabinoids eCommerce 85

Canna Care Docs

OCTOBER 3, 2023

One study supporting the efficacy of cannabinoids is in the Journal of Pain and Symptom Management, titled, “Multicenter, Double-Blind, Randomized, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract in Patients with Intractable Cancer-Related Pain.”

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Thanks to their diligence in perfecting the drug and ensuring its safety for intended use, the Drug Enforcement Agency scheduled Epidiolex under the lowest Schedule classification for controlled substances. GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. What You Should Know About Epidiolex.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

MMJ Recs

NOVEMBER 30, 2023

As the field of medical marijuana research continues to evolve, THC’s role in epilepsy management remains a topic of interest and further exploration. Clinical trials and studies are underway to examine the potential benefits and risks of MMJ as a treatment option for epilepsy. Image by Uwe Conrad from Pixabay.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

LifeCannMD

AUGUST 2, 2024

More clinical trials are needed to establish definitive efficacy and safety profiles. – Details: The research emphasized the need for controlled clinical trials to better understand the optimal dosages and strains. The study also noted that patients using medical cannabis had improved quality of life.

Clinical Trials 52

Clinical Trials Marijuana Research and Development Cannabinoids 52

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.

Research and Development 112

Research and Development Data THC Clinical Trials 112

Project CBD

FEBRUARY 28, 2023

Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. The labs analyzed 35 oils, 40 topical products, 40 edibles, 22 beverages, 55 pet products, and 29 coffee or tea products.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

MARCH 1, 2022

A fast-paced environment where you’ll work on a wide range of topics. Focus will be on IND/CTA filings and associated interactions, and may include safety reports, protocols, information amendments, responses to requests for information, IND Annual Reports/DSURs, and new investigator amendments. Position: Full-time. Opportunity.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

The Blunt Truth

AUGUST 13, 2019

On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. Two key pieces of legislation, one from each chamber of Congress, deserve attention, primarily for topical CBD products. First, Sens.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Cannabis Law Report

OCTOBER 2, 2021

A fast-paced environment where you’ll work on a wide range of topics. Focus will be on IND/CTA filings and associated interactions, and may include safety reports, protocols, information amendments, responses to requests for information, IND Annual Reports/DSURs, and new investigator amendments. San Diego, United States. Opportunity.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

Cannabis Law Report

DECEMBER 8, 2021

Charles River Laboratories, a renowned CRO engaged by Virpax to perform Food and Drug Administration (FDA) required pre-clinical studies, has completed a single dose pharmacokinetic study of dermal administration of Epoladerm in minipigs as part of the required Investigational New Drug Application (“IND”) enabling trials.

Clinical Trials 40

Clinical Trials Chronic Pain Pharmaceutical Topical 40

Cannabis Law Report

MARCH 29, 2020

This “zero recall” standard, the team said, was attributed to the fact that their cannabis product standards with regard to food safety and health was high and involved documentation of over 100 pages. . These are the responsibility of the manufacturer. Setting Standards for Cannabis Research Studies .

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

JUNE 25, 2021

The European Medicines Agency (EMA) is the regulatory body that evaluates and supervises the production and sales of medicines for safety and benefit of the customer, in the European Union Region. Key Topics Covered: 1. Celgene was founded in 1986 and is headquartered at Summit, New Jersey, United States. Executive Summary.

Research and Development 65

Research and Development Therapy Pharmaceutical Clinical Trials 65

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. It covers the pipeline drug profiles, including clinical and nonclinical stage products. What are the clinical studies going on for Epilepsy and their status?

Epilepsy 40

Epilepsy Clinical Trials Research and Development Pharmaceutical 40

Cannabis Law Report

JANUARY 19, 2022

With his extensive experience in Congress and as a policy advisor on topics including health, technology, and education, we are confident Congressman Moran will be a great asset to IGC especially at a time when we pursue Phase 2/3 human trials on IGC- AD1 on individuals that have Alzheimer’s disease.

Clinical Trials 40

Clinical Trials Research and Development Education Therapy 40

PrestoDoctor

OCTOBER 11, 2023

For years, the use of cannabis has been a controversial topic. These behaviors may include repetitive movements, specific routines or rituals, intense interests in certain topics, and a resistance to change. It is also important to address misconceptions about the legality and safety of CBD use.

CBD 52

CBD Research and Development Clinical Trials Treatment 52

MMJ Recs

DECEMBER 28, 2023

However, more research is needed to establish standardized treatment protocols and ensure the long-term safety and efficacy of medical marijuana in managing PTSD. Additionally, the method of consumption, whether through inhalation, ingestion, or topical application, can influence the onset and duration of relief.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

MMJ Recs

JULY 17, 2024

Clinical trials have highlighted the efficacy of medical marijuana in managing pain, suggesting it as a potential alternative or adjunct to traditional pain medications. Pain Management THC and CBD in medical marijuana have demonstrated analgesic properties, offering relief from chemotherapy-induced neuropathic pain and inflammation.

Marijuana 52

Marijuana Treatment Patients Therapy 52

Cannabis Law Report

SEPTEMBER 20, 2021

The products leverage pharmaceutical technology to maximize performance and safety. Additional CB4 products from the Opticann suite of branded products will be launched in the upcoming weeks, including CB4 Derma skin cream and CB4 Clear face gel skincare products uniquely backed by product specific clinical trial data.

Clinical Trials 40

Clinical Trials Pharmaceutical Data Patients 40

MMJ Recs

MAY 9, 2024

Exploring Different Consumption Methods: Medical marijuana comes in various forms, including flowers, concentrates, edibles, tinctures, and topicals. Veterans’ Access to Medical Marijuana The benefits of medical cannabis for veterans are many, but access to medical marijuana for veterans has been a topic of ongoing debate and advocacy.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

The Cannigma

JUNE 15, 2021

But the main issue with hemp derived products and their safety is less about the CBD and more about everything else in them. The main safety issues with CBD are drug interactions, and unsafe manufacturing processes due to the unregulated environment. . But that doesn’t make it completely risk free. Kevin McGovern/Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JANUARY 11, 2019

Food and Drug Administration (FDA) retains its authority to regulate ingestible and topical products, including those that contain hemp and hemp extracts such as CBD. Food and supplements that contain hemp-derived CBD are subject to a comprehensive regulatory framework that addresses both the safety and quality of these products.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Cannabis Law Report

OCTOBER 22, 2021

VSN16R was shown to be safe and well-tolerated in its Phase I clinical safety trial. INM-755: InMed Pharmaceuticals INM-755 is a cannabinol topical cream under development for the treatment of epidermolysis bullosa. Key Questions Answered. How many companies are developing Medical Marijuana – Cannabidiol drugs?

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

TheAnswerPage

JANUARY 11, 2022

For example, most, if not all, states have legalized the use of medical marijuana to treat specific health conditions for which there is no or only poor quality clinical evidence of efficacy and safety. to take a medical marijuana course that reviews the endocannabinoid system and the therapeutic use of marijuana.

Patients 98

Patients Education Marijuana Therapy 98

Medicinal Marijuana Association

FEBRUARY 11, 2024

The potential link between cannabis and glaucoma treatment is a topic of ongoing investigation, stirring both curiosity and caution within the medical community. While more clinical trials are needed to fully understand the efficacy and safety of cannabis for glaucoma treatment, current findings are promising.

Treatment 52

Treatment Blood Pressure Conditions Clinical Trials 52

Cannabis Law Report

DECEMBER 28, 2021

Epoladerm™ Epoladerm is a diclofenac topical spray film product candidate that is being developed for pain associated with osteoarthritis of the knee. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage pain associated with osteoarthritis of the knee. to conduct this study in Canada.

Pharmaceutical 40

Pharmaceutical Research and Development Clinical Trials Chronic Pain 40

Cannabis Law Report

DECEMBER 2, 2021

Below is a breakdown of the topics core training covers and the minimum hours students would devote to each subject: Historical, Traditional, and Contemporary Plant Medicine Practices and Applications (12 Hours). Safety, Ethics and Responsibilities of a Psilocybin Facilitator (10 Hours). You can contact Brett Mulligan at ?

Law 52

Law Programs Therapy Education 52

MMJ Recs

JULY 19, 2024

Clinical Research Findings: What Studies Say About Cannabis and Anxiety Numerous studies have explored cannabis’s efficacy in alleviating anxiety symptoms. However, more rigorous clinical trials are needed to establish definitive conclusions. We offer a useful bank of detailed topics on the MMJ Recs blog.

Strains 52

Strains Indica Clinical Trials Treatment 52

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 40

Clinical Trials Research and Development Data Business 40

The Cannigma

DECEMBER 22, 2021

I don’t know if we’ll have topicals initially, or later on. We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil. It has the – you assume safety, at least to a certain level. We have, I think, eight PhDs.

Research and Development 83

Research and Development Oil Cannabis Clinical Trials 83

Cannabis Law Report

OCTOBER 18, 2021

VSN16R was shown to be safe and well-tolerated in its Phase I clinical safety trial. INM-755 is a cannabinol topical cream under development for the treatment of epidermolysis bullosa. INM-755 is a cannabinol topical cream under development for the treatment of epidermolysis bullosa. INM-755: InMed Pharmaceuticals.

Research and Development 40

Research and Development Pharmaceutical Chronic Pain Therapy 40

Cannabis Law Report

NOVEMBER 10, 2021

as well as to support Good Laboratory Practices (GLP) toxicology, safety studies and preclinical efficacy studies. The NIH has contracted with a clinical research organization to conduct additional pre-clinical efficacy studies and procured a device to be used with the manufactured GMP drug product for preclinical and clinical studies.

Research and Development 40

Research and Development Chronic Pain Pharmaceutical Clinical Trials 40

Leaf Science

AUGUST 6, 2019

It is further thought that it will offer tremendous health benefits and add to the safety of athletes. The hope is that the research will help to bring about the development of a product that is topical and has CBD that will help those athletes. The Science Of CBD. The science of this product is something that is strongly believed in.

Research and Development 9

Research and Development Wellness and Beauty Banking CBD 9

MMJ Recs

AUGUST 1, 2024

Topicals, applied directly to the skin, can target localized pain and inflammation without psychoactive effects. Safety and Side Effects of Medical Marijuana While medical marijuana delivers many benefits, it still has potential side effects. Common side effects include dry mouth, dizziness, and changes in appetite.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 11, 2019

Given the controversy over the efficacy and safety of cannabis for therapeutic purposes, a key question in these cases, is whether cannabis meets the requirement of medical justification. The physiatrist recommended cannabis in three forms: a topical cream, a tincture of oil, and an oral capsule. Siegrist with approval. ” 42.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45